← Leaderboards
Floyd L. Wormley
University Of Texas San Antonio
$7,201,544
Attributed
$9,273,197
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,273,197 · 9
By mechanism
R01$5,776,726 · 2
R21$1,753,965 · 5
R33$1,332,370 · 1
R15$410,136 · 1
Top collaborators
- J. Andrew Alspaugh5 shared
- Jose L. Lopez-Ribot4 shared
- Anton Naumov1 shared
Most similar at University Of Texas San Antonio
Same institution · by research overlap
- Jose L. Lopez-Ribot$7,729,701
- Sarah Beth Saeger$37,513
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionImmuneLeadImmune ResponseMycosesBaseLifeCryptococcus NeoformansMorbidity - Disease RateAcquired Immunodeficiency SyndromeResponseImmunityCryptococcus Neoformans InfectionLungInflammatory ResponseAntifungal AgentsVaccinesPathogenFungusPreventLaboratoriesMortalityImmunizationEngineering
Grant awards (29)
Induction of Protective Immune Responses Against C. neoformans in Immune Compromised Hosts$153,580
R21 · FY2025 · AI · contact PI
Induction of Protective Immune Responses Against C. neoformans in Immune Compromised Hosts$182,359
R21 · FY2024 · AI · contact PI
Screening a Target-Based Repurposing Library for Activity against Fungal Pathogens and Subsequent Preclinical Development of Leading Candidates$444,415
R33 · FY2023 · AI
Screening a Target-Based Repurposing Library for Activity against Fungal Pathogens and Subsequent Preclinical Development of Leading Candidates$444,415
R33 · FY2022 · AI
5-Lipoxygenase Inhibition as a Therapy to Prevent Cryptococcus-related IRIS$145,825
R21 · FY2022 · AI · contact PI
Screening a Target-Based Repurposing Library for Activity against Fungal Pathogens and Subsequent Preclinical Development of Leading Candidates$443,540
R33 · FY2021 · AI
Biocompatible Graphene Quantum Dots for Noninvasive Near-infrared Bioimaging$410,136
R15 · FY2021 · EB
5-Lipoxygenase Inhibition as a Therapy to Prevent Cryptococcus-related IRIS$170,219
R21 · FY2021 · AI · contact PI
Coordinated Regulation of Virulence Genes in C. neoformans$409,017
R01 · FY2020 · AI
Coordinated Regulation of Virulence Genes in C. neoformans$409,017
R01 · FY2019 · AI
Screening a Target-Based Repurposing Library for Activity against Fungal Pathogens and Subsequent Preclinical Development of Leading Candidates$313,188
R21 · FY2019 · AI
Coordinated Regulation of Virulence Genes in C. neoformans$409,017
R01 · FY2018 · AI
Protective Host Immunity Against Pulmonary Cryptococcosis$407,041
R01 · FY2018 · AI · contact PI
Coordinated Regulation of Virulence Genes in C. neoformans$409,017
R01 · FY2017 · AI
Protective Host Immunity Against Pulmonary Cryptococcosis$408,541
R01 · FY2017 · AI · contact PI
Coordinated Regulation of Virulence Genes in C. neoformans$451,544
R01 · FY2016 · AI
Protective Host Immunity Against Pulmonary Cryptococcosis$367,500
R01 · FY2016 · AI · contact PI
Protective Host Immunity Against Pulmonary Cryptococcosis$39,541
R01 · FY2016 · AI · contact PI
Protective Host Immunity Against Pulmonary Cryptococcosis$367,500
R01 · FY2015 · AI · contact PI
Protective Host Immunity Against Pulmonary Cryptococcosis$367,500
R01 · FY2014 · AI · contact PI
Induction of Protection Against Cryptococcus neoformans in Immune Deficient Hosts$172,725
R21 · FY2013 · AI · contact PI
Induction of Protection Against Cryptococcus neoformans in Immune Deficient Hosts$220,500
R21 · FY2012 · AI · contact PI
Protective Host Immunity Against Pulmonary Cryptoccoccosis$340,124
R01 · FY2011 · AI · contact PI
Identification of C. neoformans proteins that induce protective immunity.$178,819
R21 · FY2011 · AI · contact PI
Protective Host Immunity Against Pulmonary Cryptoccoccosis$343,559
R01 · FY2010 · AI · contact PI
Identification of C. neoformans proteins that induce protective immunity.$216,750
R21 · FY2010 · AI · contact PI
Protective Host Immunity Against Pulmonary Cryptoccoccosis$347,029
R01 · FY2009 · AI · contact PI
Protective Host Immunity Against Pulmonary Cryptoccoccosis$347,029
R01 · FY2008 · AI · contact PI
Protective Host Immunity Against Pulmonary Cryptoccoccosis$353,750
R01 · FY2007 · AI · contact PI